CREDIT SUISSE AG/ - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 77 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$6,000
-98.3%
48,981
-76.1%
0.00%
Q3 2018$348,000
-25.6%
205,005
-23.8%
0.00%
Q2 2018$468,000
-13.8%
269,003
-9.3%
0.00%
-100.0%
Q1 2018$543,000
-16.7%
296,444
+1.4%
0.00%0.0%
Q4 2017$652,000
-35.1%
292,398
-15.6%
0.00%0.0%
Q3 2017$1,004,000
-44.0%
346,278
-14.1%
0.00%
-50.0%
Q2 2017$1,792,000
-47.2%
402,894
-44.7%
0.00%
-33.3%
Q1 2017$3,395,000
+131.4%
728,352
+202.3%
0.00%
+200.0%
Q4 2016$1,467,000
+7.3%
240,918
-2.9%
0.00%0.0%
Q3 2016$1,367,000
+84.2%
248,027
+27.1%
0.00%0.0%
Q2 2016$742,000
-4.9%
195,140
-30.9%
0.00%0.0%
Q1 2016$780,000
-39.0%
282,265
+25.3%
0.00%0.0%
Q4 2015$1,278,000
+29.4%
225,293
+21.0%
0.00%0.0%
Q3 2015$988,000
-40.5%
186,255
-6.8%
0.00%
-50.0%
Q2 2015$1,660,000
+288.8%
199,916
+116.4%
0.00%
Q1 2015$427,000
+6.0%
92,375
-30.1%
0.00%
Q4 2014$403,000
+8.0%
132,059
-1.4%
0.00%
Q3 2014$373,000
-48.6%
133,906
-24.9%
0.00%
-100.0%
Q2 2014$726,000
+5.1%
178,386
+37.0%
0.00%0.0%
Q1 2014$691,000
+3.6%
130,193
+9.9%
0.00%0.0%
Q4 2013$667,000
+61.1%
118,479
+30.8%
0.00%
Q3 2013$414,000
-47.7%
90,562
-50.6%
0.00%
-100.0%
Q2 2013$792,000
+97.0%
183,357
+177.3%
0.00%
Q1 2013$402,00066,1330.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2014
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,200,000$6,072,0002.38%
GREAT POINT PARTNERS LLC 2,175,000$6,003,0002.15%
Belmont Global Advisors, Inc. 400,000$1,104,0001.12%
Trellus Management Company, LLC 162,900$450,0000.78%
PURA VIDA INVESTMENTS, LLC 572,800$1,581,0000.72%
DAFNA Capital Management LLC 294,563$813,0000.70%
Twin Securities, Inc. 1,687,115$4,656,0000.58%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 1,000,000$2,760,0000.33%
WALL STREET ASSOCIATES 269,300$743,0000.31%
Paulson & Co. 11,090,000$30,608,0000.23%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders